With a focus on expanding your community and exploring the latest industry developments at this two-day event, including key regulatory updates and key case studies from leading pharmaceutical companies and biotechnology.
Register your spot online at: http://highlypotentapi.com/PR4PRCOM
SMi caught up
Considering that high potency APIs continue to be an important aspect of pharmaceutical manufacturing, have you seen any changes regarding their handling or discussion in the past year?
The health and safety of employees is always a top priority for our company. On the business side, we strive to develop and integrate management systems into site operations, particularly those handling compounds that may pose higher risks due to their inherent hazards. Although there have been many discussions during the COVID-19 pandemic about the relevance of risks versus hazards, the difference remains a challenge to communicate.
What is the biggest challenge you personally face in the Highly Potent API space right now?
There has been a shift in operations to include new technologies and to use old technologies in a more sustainable way. At Takeda, we strive to be a leader in sustainability. The combination of sustainability thinking and health protection requires experts from both sides to have a common conversation, not to move risks up the value chain. An example of these synergies was recently published by Schmidt and Guytingco in an article titled
What topic will you address in your presentation and what would you say will make it relevant to the audience in 2022?
The subject of safety limits is reaching us more and more. We know our planetary limits, and we also have limits for the chemicals we are exposed to. I will talk about these limits.
Ester will present the first day of the conference on “The Dangers and Power of New Therapeutic Modalities” which covers:
Assess the relevance, adequacy and reliability of data
Determination of exposure limits in the absence of data
Nucleic Acids Case Study
Download the brochure at: http://highlypotentapi.com/PR4PRCOM
SMi offers sponsorship, exposure, advertising and branding packages, specially designed to complement your company’s marketing strategy. For further details and all delegate enquiries, please contact
6th edition of SMi
Conference: 9th –
Established since 1993, the
+44 (0) 20 7827 6154
Contact by email
Read the full story here: https://www.pr.com/press-release/858884
Press release distributed by PR.com
Copyright © 2022 PR.com and its licensors, source